Sir Tom McKillop started his career in ICI in 1969 following post-doctoral research work in Paris. In ICI Pharmaceuticals Division he held various positions of increasing responsibility in research and development, including Director of Research in France, General Manager ( Research) and General Manager (Development). In 1989 he was appointed Technical Director of ICI Pharmaceuticals, a position in which he was responsible for global Research, Development, Clinical and Production. In 1992 he was appointed Deputy CEO and in 1994 he became CEO of Zeneca Pharmaceuticals. In 1999 he led the merger of Astra and Zeneca, becoming Executive Director of AstraZeneca plc, a position he held until he retired at the end of 2005. Until 2009 he was Chief Executive of the Royal Bank of Scotland and NonExecutive Director of BP. He has also worked as Senior Non-Executive Director of Lloyds TSB Group and was Non-Executive Director of Amersham International before it was acquired by General Electric. He has been President of the European Federation of Pharmaceutical Industries Associations, President of the Pharmaceutical Industry Task Force and a member of the European Round Table of Industrialists and the European Financial Roundtable. He was President of the Science Council from 2008 to 2011. He has received several academic awards and grants. He is a member of The Royal Society and the Royal Society of Edinburgh, a member of The Academy of Medical Sciences, honorary member of The Royal Society of Chemistry and an honorary member of The Institute of Chemical Engineers.

 Active Ingredient, Therapeutic Area or Country filters, Dermatologicals, Nervous system